Unknown

Dataset Information

0

A natural food sweetener with anti-pancreatic cancer properties.


ABSTRACT: Mogroside V is a triterpenoid isolated from the traditional Chinese medical plant Siraitia grosvenorii. Mogroside V has a high degree of sweetness and a low calorific content. Herein, we found that mogroside V possesses tumor growth inhibitory activity in in vitro and in vivo models of pancreatic cancer by promoting apoptosis and cell cycle arrest of pancreatic cancer cells (PANC-1 cells), which may in part be mediated through regulating the STAT3 signaling pathway. These results were confirmed in vivo in a mouse xenograft model of pancreatic cancer. In xenograft tumors, Ki-67 and PCNA, the most commonly used markers of tumor cell proliferation, were downregulated after intravenous administration of mogroside V. Terminal deoxynucleotidyl transferase dUTP nick end labeling assays showed that mogroside V treatment promoted apoptosis of pancreatic cancer cells in the xenograft tumors. Furthermore, we found that mogroside V treatment significantly reduced the expression of CD31-labeled blood vessels and of the pro-angiogenic factor vascular endothelial growth factor in the xenografts, indicating that mogroside V might limit the growth of pancreatic tumors by inhibiting angiogenesis and reducing vascular density. These results therefore demonstrate that the natural, sweet-tasting compound mogroside V can inhibit proliferation and survival of pancreatic cancer cells via targeting multiple biological targets.

SUBMITTER: Liu C 

PROVIDER: S-EPMC4848839 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A natural food sweetener with anti-pancreatic cancer properties.

Liu C C   Dai L-H LH   Dou D-Q DQ   Ma L-Q LQ   Sun Y-X YX  

Oncogenesis 20160411


Mogroside V is a triterpenoid isolated from the traditional Chinese medical plant Siraitia grosvenorii. Mogroside V has a high degree of sweetness and a low calorific content. Herein, we found that mogroside V possesses tumor growth inhibitory activity in in vitro and in vivo models of pancreatic cancer by promoting apoptosis and cell cycle arrest of pancreatic cancer cells (PANC-1 cells), which may in part be mediated through regulating the STAT3 signaling pathway. These results were confirmed  ...[more]

Similar Datasets

| S-EPMC8708931 | biostudies-literature
| S-EPMC4616216 | biostudies-literature
| S-EPMC5456284 | biostudies-literature
| S-EPMC5872752 | biostudies-literature
| S-EPMC8240050 | biostudies-literature
| S-EPMC6559640 | biostudies-literature
| S-EPMC5966364 | biostudies-literature
| S-EPMC8299011 | biostudies-literature
| S-EPMC6997147 | biostudies-literature
| S-EPMC7070548 | biostudies-literature